Year Wise Statistics
Total Downloads
464,006
Fulltext
347,804
PDF
116,202
464,006
Fulltext
347,804
116,202
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text |  PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023 |
20,590 | 1,984 | 22,574 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023 |
20,605 | 1,736 | 22,341 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023 |
19,646 | 1,725 | 21,371 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023 |
19,510 | 1,678 | 21,188 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023 |
16,739 | 1,403 | 18,142 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024 |
16,268 | 1,835 | 18,103 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024 |
15,769 | 2,320 | 18,089 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024 |
15,974 | 2,050 | 18,024 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023 |
15,978 | 1,833 | 17,811 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023 |
15,693 | 1,242 | 16,935 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020 |
9,570 | 1,104 | 10,674 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022 |
6,284 | 1,329 | 7,613 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023 |
6,060 | 1,481 | 7,541 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023 |
5,627 | 1,024 | 6,651 |
Review ArticleCombination of PARPi and anti-PD-L1 therapies in ovarian cancerFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022 |
5,800 | 792 | 6,592 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022 |
5,900 | 599 | 6,499 |
Original ArticleReal-world study on the effect of nab-paclitaxel treatment on clinical outcomes and laboratory parameters in patients across metastatic tumor sitesFull text | PDF DOI: 10.25259/IJMIO_5_2024 |
5,269 | 663 | 5,932 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
3,755 | 712 | 4,467 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_5_2023 |
2,866 | 730 | 3,596 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022 |
1,523 | 1,998 | 3,521 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019 |
2,603 | 914 | 3,517 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022 |
1,855 | 1,057 | 2,912 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020 |
1,793 | 1,048 | 2,841 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020 |
1,841 | 959 | 2,800 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022 |
1,862 | 880 | 2,742 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019 |
1,824 | 850 | 2,674 |
Review ArticleImpact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic reviewFull text | PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019 |
1,277 | 1,316 | 2,593 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021 |
1,272 | 1,287 | 2,559 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021 |
1,217 | 1,336 | 2,553 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December |
1,627 | 924 | 2,551 |
Original ArticleAdvanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation regionFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2021 |
1,454 | 991 | 2,445 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020 |
1,480 | 942 | 2,422 |
Review ArticleAlpha-fetoprotein: A molecular bootstrap for hepatocellular carcinomaFull text | PDF Year: 2020, Volume: 5, Issue: 3, September-December DOI: 10.25259/IJMIO_5_2020 |
1,859 | 512 | 2,371 |
Review ArticleMolecular targets in urinary bladder cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_4_2022 |
1,603 | 742 | 2,345 |
Brief CommentaryERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginningFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021 |
966 | 1,333 | 2,299 |
Review ArticleClinical trials landscape in Sri LankaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_29_2020 |
1,709 | 579 | 2,288 |
Review ArticleResistance to poly ADP-ribose polymerase inhibitors and its clinical implicationsFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022 |
1,195 | 1,082 | 2,277 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019 |
1,295 | 961 | 2,256 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021 |
1,113 | 1,135 | 2,248 |
Review ArticleClinical application of molecular genetics in acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_22_2022 |
1,621 | 553 | 2,174 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021 |
1,211 | 937 | 2,148 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
1,486 | 593 | 2,079 |
Original ArticleMultiple gene silencing in STAT pathway in K562 cellsFull text | PDF Year: 2019, Volume: 4, Issue: 1, January-April DOI: 10.25259/IJMIO-5-2019 |
1,498 | 518 | 2,016 |
Case ReportCHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathwayFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_25_2022 |
1,551 | 459 | 2,010 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022 |
1,051 | 953 | 2,004 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022 |
1,196 | 801 | 1,997 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021 |
1,200 | 771 | 1,971 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021 |
1,201 | 765 | 1,966 |
EditorialMolecular insights into tumor microenvironment and targeted therapiesFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_28_2021 |
816 | 1,140 | 1,956 |
Review ArticleImmuno-oncological era of breast cancer: A progressive path to better treatmentFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022 |
1,086 | 817 | 1,903 |
